Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Predictive Oncology Inc POAI

Healthcare Medical Devices
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples... see more

Recent & Breaking News (NDAQ:POAI)

Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire 11 days ago

Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery

GlobeNewswire August 27, 2024

Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire August 14, 2024

Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development

GlobeNewswire August 13, 2024

Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

GlobeNewswire August 7, 2024

Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds

GlobeNewswire July 26, 2024

Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results

GlobeNewswire July 25, 2024

Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)

GlobeNewswire June 11, 2024

Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery

GlobeNewswire June 4, 2024

Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024

GlobeNewswire May 29, 2024

Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire May 28, 2024

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire May 15, 2024

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

GlobeNewswire May 10, 2024

Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine

GlobeNewswire April 30, 2024

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire April 24, 2024

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

GlobeNewswire March 28, 2024

Predictive Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire February 21, 2024

Predictive Oncology to Participate in Upcoming San Francisco Conferences

GlobeNewswire January 2, 2024

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire November 14, 2023

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

GlobeNewswire November 8, 2023